OBI-1 (modified recombinant Factor VIII)

modified recombinant Factor VIII · Baxalta (now part of Shire)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OBI-1 (modified recombinant Factor VIII), covering 2014-12-17 to 2014-12-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Congenital Hemophilia A [Phase 3]